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Background:P revalence of metabolic syndrome (MS) in obese
adolescents has been reported to range between 18–42%,
depending on country of origin, thus suggesting an ethnic-
based association between obesity and MS.
Aim:T his study aims to investigate the magnitude of the
association between obesity, insulin resistance and
components of MS among adolescents in Lebanon.
Subjects and methods:T he sample included 263 adolescents at
4
th and 5
th Tanner stages of puberty (104 obese; 78
overweight; 81 normal weight). Anthropometric, biochemical
and blood pressure measurements were performed. Body fat
was assessed using dual-energy X-ray absorptiometry.
Results:A ccording to International Diabetes Federation
criteria, MS was identiﬁed in 21.2% of obese, 3.8% of
overweight and 1.2% of normal weight subjects. The most
common metabolic abnormalities among subjects having MS
were elevated waist circumference (96.2%), low HDL (96.2%)
and hypertriglyceridemia (73.1%). Insulin resistance was
identiﬁed in all subjects having MS. Regression analyses
showedthat percentagebody fat, waist circumferenceand BMI
were similar in their ability to predict the MS in this age group.
Conclusions:M Sw as identiﬁed in as ubstantial proportion of
Lebanese obese adolescents, thus highlighting the importance
of early screening for obesity-associated metabolic
abnormalities and of developing successful multi-component
interventions addressing adolescent obesity.
Keywords: Metabolic syndrome, obesity, body fat, BMI, waist
circumference, insulin resistance, adolescents, Lebanon
BACKGROUND
The prevalenceo fp aediatric obesityh as increased over the
last decades in manyc ountries, with estimates indicating
higher obesityp revalencea mong adolescents in the Eastern
Mediterranean Region( EMRO) than that reported from
Europe and the US (Kelishadi 2007). The increase in the
prevalenceo fo besityi ny ouths has been parallelled by an
increase in the prevalenceo fp aediatric metabolic syndrome
(MS), ac onstellationo fm etabolic risk factors that include
insulin resistance, hypertension,g lucose intolerance and an
abnormal lipid proﬁle (Weiss et al.2 004; Esmaillzadeh et al.
2006; Braga-Tavares and Fonseca2 010). Ar ecent study
conducted in Turkey showed that, among 2–19 year old
children and adolescents,aone-point increase in BMI
Z -score resulted in a2 -foldi ncrease in the prevalence of MS
(Sen et al. 2008).
Based on the modiﬁedA TPIII criteria (Cook et al. 2003),
prevalencee stimates of MS among obesea dolescents were
found to varyb etween 18% in Spain and 42% in the US,
suggesting an ethnic-based associationb etween obesitya nd
MS (Lo ´ pez-Capape ´ et al.2 006;D huper et al. 2007). Limited
data from the Middle-East suggest highr ates of MS and
cardiometabolic risk factorsi nt he adolescent population.
The prevalenceo fM Sa mong obesea dolescents in Iran is
among the highest estimatesr eportedi nt he literature
(41.9%)( Esmaillzadeh et al. 2006). Similarly,i narecent
study conducted on 203 overweight and obese subjects aged
6–17 years living in Norway,t he prevalence of MS was
found to be higher among obese subjects with Middle
Eastern origins than among their Norwegian counterparts
(30.6% vs 20.8%)( Kolsgaard et al. 2008). This association
between adolescent obesitya nd MS indicators has not been
investigated in manyc ountries of the Middle-East.
Althoughr ecent deﬁnitions of MS do not include direct
measurement of insulin in children (Eyzaguirrea nd Mericq
2009), insulin resistance (IR) has been frequently reported
to overlap with MS and to confer cardiometabolic disease
risk distinct from that attributed to MS itself (Haffner et al.
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1221990; Dhuper et al. 2007;S teinbergere ta l. 2009). Ethnic
disparities in insulinr esistanceh avea lso been reported in
the literature,w ith insulin resistance suggested as being
more frequent in Whitea nd African-Americanp eople and
less common in Asiatic, Arabic andL atin American
populations (Caceres et al. 2008).
EventhoughtheclinicalutilityofMSasadiseasecategory
faces considerable controversy,p articularly when applied
to the paediatric population, the screening for MS and
its components early in life allows for the identiﬁcation
of individualsa ts igniﬁcantr isk for cardiovasculard isease
and those in urgent need of lifestyle intervention. Recent
evidence suggests the presenceo fe arly functional and
morphologic changes to the hearta nd blood vessels among
obese adolescents with MS (Chinali et al. 2008). Yet, the
plasticityo ft he cardiovascular system early in life allows
for the reversal of cardiovascular damage and cardiac
abnormalities in obese adolescents, but only if risksa re
identiﬁed early and treated aggressively (Ippisch et al. 2008;
Battistae ta l. 2009). Fort hese reasons, the identiﬁcation of
paediatricM Si ni ndividuals who haven ot yet developed
cardiovasculard isease, is of great importance from ap ublic
health perspective.
This study was conducted to investigate the magnitude
of thea ssociation between obesity,i nsulin resistance
and variousc omponents of the MS among adolescents
(Tanners tages4 –5)i nL ebanon,asmallE astern
Mediterranean country, where prevalencer ates of paediatric
obesitya re high, approaching those observed in developed
countries such as the US (Sibai et al. 2003).Conﬁrming
MS prevalencei nL ebanese obese adolescents should lead
to multi-component interventions targeting MS and its
components in Lebanona nd other parts of the Middle-East.
METHODS
Study design and participants
This is ac ross-sectional study of adolescents attending
public schoolsi nB eirut. The research wasa pproved
by the Institutional Review Board, American University
of Beirut.
As ample of 263 subjects was recruitedu sing am ulti-
stage cluster samplinga sf ollows. Out of 74 publics chools in
Beirut, eight were randomly selectedf rom the list of the
Lebanese Ministry of Education. From grades 10, 11 and 12,
aB MI-stratiﬁed samplew as conveniently recruited.
Stratiﬁcation was based on BMI status as deﬁned by the
newW HO growth standards (deO nise ta l. 2007).
Accordingly,o besityw as deﬁned as BMI . þ 2 Z -scores
for sex and age, overweight as þ 1 , BMIZ -scores # þ 2
and normal weight as BMI # þ 1B MI Z -scores (de Onis
et al. 2007). Written informedc onsent from parents and
written informed assentf rom participants wass ought.
Subjects were invited to visit the research centrea tt he
Nutrition and Food Science Department at the American
University of Beiruta nd were instructed to consume ad aily
diet providing 50–60% of energyi ntake as carbohydrates
for 3d ays prior to their visit and to avoid anyv igorous
physical activity. Eligibilityo fs tudy subjects was veriﬁed.
Subjects were eligible if they were healthy, at 4
th and 5
th
Tanner stages of puberty, as determined by am edicald octor,
and of Lebanese ancestry. Exclusionc riteriai ncluded history
of chronic illness or the use of medications that alter blood
pressure, glucose or lipid metabolism.
Samples ize calculation wasb ased on the following:
To detectam oderate correlation ( r )o farange of 0.2–0.3
between obesitya nd componentso ft he metabolic
syndrome, as ample of 68–150 subjects was needed to
provide an 80% power at p ¼ 0.05.
Data collection
Data collection was carried outi n2 008–2009o n
participantsw ho matchedi nclusionc riteriaa nd had
providedw ritten assent as well as parental written informed
consent. Anthropometric measurements were taken after
voiding and included weight, height, WC and %BF which
was measured by dual-energyX -ray absorptiometry( DXA)
(DelphiW ,H ologic Inc, QDR software for windows
version 11.2) based on region %BF.W aist circumference
(WC) was measured using ac alibrated plasticm easuring
tape, at the umbilicus level, with subjectss tanding and
following normal expiration (Marfell-Jones et al. 2006).
Fasting blood samples (10ml/participant) were obtained
by ap hlebotomist for the analysis of serum glucose, insulin,
triglycerides (TG) and HDL. Blood pressurew as measured
by ar egisteredn urse using am ercurys phygmomanometer,
with the subjects seated anda fter a5 -minute rest.
Biochemical analysis
Plasma glucose was analysed using the COBAS 6000 ana-
lyzer (Roche Diagnostics, Switzerland). Serum insulin was
determined by the use of an antibody radioimmunoassay kit
(Linco Research, Missouri, USA). Serum TG was deter-
mined using the COBAS 6000 analyzer (Roche Diagnostics,
Switzerland)w hile serum HDLw as colourimetrically
determined by the use of the HDLs eparationt ab (Union
Carbide Corp.P leasantville, NY,U SA).
Diagnostic criteria for the metabolic syndrome
MSwas deﬁned based on the recently published harmonized
metabolics yndrome deﬁnition( Albertie ta l. 2009),
according to which three abnormal ﬁndingso ut of ﬁve
would qualify the subject for the MS. The cut-off values for
the individual metabolic abnormalities are based on the
IDF criteria (Zimmet et al. 2007), which recommend
the use of the adult IDF cut-off valuesf or subjects aged
16 yearsa nd older, as follows:a bdominal obesity
(WC $ 94cm for males and $ 80cm for females); elevated
TG ( $ 150mg/dL); low levels of HDL ( , 40mg/dL for
males and , 50mg/dL for females); highs ystolic blood
pressure( SBP) ( $ 130mmHg) or highd iastolic blood
pressure( DBP) ( $ 85mmHg);h ighf asting glucose
( $ 100mg/dL). Fors ubjects aged 10–16y ears,t he IDF
recommends the use of the same diagnosticc riteriae xcept
for WC and HDL,w here WC $ 90
th percentile for age and
sex, and HDL , 40mg/dL were useda sc ut-off values. For
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ing to the modiﬁed ATPI II deﬁnition (Cook et al. 2003).
As reference values speciﬁc for adolescents in Lebanon
are not available, hyperinsulinemia was determined based
on cut-off points speciﬁc for the Tanner stage of maturation
(fastingi nsulin $ 30mIU/L for Tanner stage 4; fasting
insulin $ 20mIU/L forT anners tage 5) proposedb y
the literature (Goran and Gower 2001; Sen et al. 2008).
Insulin resistance( IR) wasd etermined using the homeo-
static model assessment of insulinr esistance (HOMA-IR)
deﬁned as:
FastingPlasmaInsulin ð mIU= L Þ
£ FastingGlucoseð mmol = L Þ = 22: 5
Values exceeding 3.16 indicated the presenceo fI R( Keskin
et al. 2005).
Statistical analysis
Statistical analysis was performed using the Statistical
Analysis Package forS ocial Sciences (SPSS, version 16.0)
and the level of signiﬁcance was set at p , 0.05. Frequencies
and descriptive statistics were performed fort he different
variables unders tudy including MS prevalence according to
different deﬁnitionsa sw ell as the prevalence of individual
components of MS. Means and standard deviations were
computed for anthropometric and biochemical variables.
Mean differences were compared for signiﬁcanceb etween
groups, using one-way ANOVA.P earsonc orrelations were
performedb etween obesityi ndicators and the different MS
components. The associationb etween MS abnormalities
(dependant variables) and adiposityi ndicators including
%BF,W Ca nd BMI (independent variables) was assessed by
age and sex-a djusted linear regression analyses. Natural
logarithm transformation was performed when the depen-
dent variable was not normally distributed. Determinants of
MS were evaluatedu sing age- and sex-adjusted logistic
regression analysis.
RESULTS
The study sample consisted of 263 adolescents (112 males
and 151 females) and included1 04 obese,7 8o verweight and
81 normal weight subjects.A nthropometric, biochemical
and blood pressurem easurements of the studys ubjects
are shown in Table I. Genders combined, mean serum TC,
LDL-C, TG,i nsulin levels, systolic and diastolic blood
pressurew eres igniﬁcantly higher and HDL-C signiﬁcantly
lower in obesea sc ompared to normal weight adolescents.
The most common abnormalitya mong obesea dolescents
was elevated WC (90.4%), followed by IR (88.5%) and
hyperinsulinemia (73.1%), while hyperglycemia wast he
least common abnormality( 3.8%) (Table II).
The number of metabolic abnormalities increased with
obesity( Table III), whereby1 9.2% of obese subjects had
three metabolic abnormalities as compared to 3.8% of
overweight subjects and 1.2% of the normal weight subjects.
The presenceo ff our metabolic abnormalities was only
noted among obese subjects (1.9%). Based on IDF criteria,
the prevalence of MS was 21.2%i no beses ubjects, 3.8% in
overweight subjects and 1.2% in the normal weight subjects.
Analysing the data according to the modiﬁed ATPI II
deﬁnition (Cook et al. 2003)y ielded as lightly higher
prevalenceo fM Si nt he obese study sample (24.0%), while
MS prevalence among overweighta nd normal weight
subjects remainede ssentially the same( 3.8% in overweight
and 1.2% in normal weight subjects). Gender disparities
were noted with both the IDF (27.1% in obeseb oys and
16.1% in obese girls) and ATPIII (31.3%i no beseb oys and
17.9% in obese girls) deﬁnitions, with obese boys showing
higher prevalence rates of MS.
Table I. Baseline characteristics of the adolescent subjects.
Adolescents
Characteristics
Obese . þ 2B MI z -scores
( n ¼ 104)
Overweight þ 1 , BMI z -scores $ þ 2
( n ¼ 78)
Normal weight # þ 1B MI z -scores
( n ¼ 81)
Age (years), mean ^ SD 16.07  ^ 1.30 16.39  ^ 1.44 16.80  ^ 1.27
Anthropometric data, mean ^ SD
BMI (Kg/m
2 )3 2.52  ^ 3.39
a 26.38  ^ 1.35
b 20.87  ^ 1.98
c
Body Fat (DXA) (%) 38.86  ^ 5.65
a 32.95  ^ 7.29
b 23.60  ^ 8.76
c
WC (cm) 97.87  ^ 11.57
a 85.16  ^ 8.95
b 73.06  ^ 8.38
c
Biochemical and blood pressured ata, mean ^ SD
TC (mg/dL) 156.78  ^ 27.34
a 154.19  ^ 30.44
a 141.63  ^ 21.92
b
HDL (mg/dL) 43.66  ^ 10.52
a 46.80  ^ 10.33
b 48.10  ^ 9.98
b
LDL (mg/dL) 93.84  ^ 25.74
a 90.60  ^ 26.72
a 79.86  ^ 18.69
b
TG (mg/dL) 105.09  ^ 50.39
a 85.58  ^ 42.76
b 68.31  ^ 26.05
c
FBG (mg/dL) 88.62  ^ 8.10
a 88.62  ^ 7.11
a 89.46  ^ 5.48
a
Insulin ( m U/mL) 33.55  ^ 18.37
a 26.42  ^ 14.38
b 10.64  ^ 7.89
c
SBP (mmHg) 117.38  ^ 11.97
a 113.08  ^ 9.98
b 113.65  ^ 10.41
b
DBP (mmHg) 70.67  ^ 8.16
a 66.99  ^ 6.95
b 65.33  ^ 5.44
b
a ,
b ,
c Values in the same roww ithd ifferent superscripts aresigniﬁcantly different, p , 0.05 (one-wayANOVA between normalweight vs overweight vs
obese groups).
The deﬁnitions of overweight and obesityw ere based on sex- and age-speciﬁc þ 1a nd þ 2B MI z -scores, respectively,d erived from WHO child growth
standards (de Onis et al. 2007).
DBP,D iastolic Blood Pressure; FBG, Fasting Blood Glucose; HDL-C, High DensityL ipoprotein-Cholesterol; SBP,S ystolic Blood Pressure; TC,T otal
Cholesterol; TG,T riglycerides; WC,w aist circumference.
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metabolic abnormalities as deﬁned by the IDF were elevated
waistc ircumference( 96.2%) andl ow HDL( 96.2%)
followed by hypertriglyceridemia (73.1%), while the least
common metabolic abnormalityw as hyperglycaemia(7.7%)
(Table IV).
IR wasi dentiﬁed in 88.5% of obese,8 4.6% of overweight
and24.7%ofnormalweightadolescents(TableII).Similarly,
IR and hyperinsulinemiawerepresent in 100% and 73.1% of
subjects diagnosed with MS, respectively (Table IV).
Correlationa nalysiss howedt hat, amongs ubjectso fb oth
genders,bothBMIandWC weresigniﬁcantlynegativelycorre-
latedw ithH DL ands igniﬁcantlyp ositivelyc orrelatedw ith
TG,S BP,D BP andi nsulin levels,w hile %BFw as positively
associated withT G, DBP, insulinl evelsa nd IR (Table V).
Age- and sex-adjusted linear regression analysis showed
that all threea dipositym arkers (BMI, WC and %BF) were
signiﬁcantp redictors of TG,I nsulin,S BPand DBP (data not
shown). Regression analyses alsos howed that BMI
(OR ¼ 1.255; 95% CI ¼ 1.144–1.377), %BF (OR ¼ 1.157;
95%C I ¼ 1.082–1.239)a nd WC (OR ¼ 1.081; 95%
CI ¼ 1.044–1.119) were all signiﬁcantp redictors of MS in
the study sample.
DISCUSSION
This study is the ﬁrst, to ourk nowledge, to examinet he
association between obesitya nd MS indicators among
adolescents from the Levant area in the Middle-East. It
showed that obesityi ncreases the risko fd eveloping MS
among Lebanese adolescents (13–19y ears) of Tanner stages
4–5. The prevalence of MS was estimated at 21.2%i no bese
adolescents using IDF criteria, with obese boys presenting a
higher rate as compared to obese girls. Abdominal obesity,
reducedH DL-levels and hypertriglyceridemiaa ppeared as
the main abnormalities contributing to the syndrome.
Various deﬁnitions of paediatricM Sh aveb een used in
the literature with varied sets of criteria and different cut-off
values for each risk factor,m aking disparitiesa cross studies
difﬁcult to appraise (Cook et al. 2003; de Ferranti et al.
2004; Weisse ta l. 2004;K arachaliou et al. 2008). For
comparison purposes, the prevalence of MS in this study
was re-calculated using the ATPI II deﬁnition (Cook et al.
2003) and results were contrasted with those obtained from
ther egiona nd elsewhere. Findings indicate thatt he
prevalenceo fM Sa mong obese adolescents in Lebanon
(24%) is notably high, exceeding that reported from
developed countries such as Italy (16.5%) (Caranti et al.
2008) and Spain (18.0%)( Lo ´ pez-Capape´ et al. 2006), while
being lower than that reported from the US (42%) (Dhuper
et al. 2007), the UAE( 44%)( Eapen et al. 2010) and Iran
(41.9%)( Esmaillzadeh et al. 2006). This discrepancy in MS
prevalencea mong obesea dolescents is in line with the
assumptions of an ethnic-baseda ssociationb etween obesity
and MS indicators.S everal studies haves uggested that the
impacto fo besity, particularly abdominal obesityo nM S
Table II. Prevalence of individual metabolic abnormalities by BMI classiﬁcation.
Adolescents, n (%)
Individual abnormalities
Obese . þ 2B MI z -scores
( n ¼ 104)
Overweight þ 1 , BMI
z -scores # þ 2( n ¼ 78)
Normal weight # þ 1B MI
z -scores ( n ¼ 81)
Elevated Waist Circumference
a 94  (90.4) 36  (46.2) 3  (3.7)
Low HDL
a 45  (43.3) 29  (37.2) 27  (33.3)
High tryglycerides
a 21  (20.2) 6  (7.7) 1  (1.2)
Hypertension
a 18  (17.3) 5  (6.4) 9  (11.1)
High fasting glucose
a 4  (3.8) 6  (7.7) 3  (3.7)
Insulin resistance
b 92  (88.5) 66  (83.3) 20  (24.7)
Hyperinsulinemia
c 76  (73.1) 45  (57.7) 7  (8.6)
a As deﬁned by IDF Criteria:
. Elevated Waist Circumference (WC): For subjects 16 years and older,W C $ 94cm for males and $ 80cm for females. For ages 13–15y ears, WC $ 90th
percentiles or adult cut-off value if lower;
. Low HDL: For subjects 16 years and older HDL , 40mg/dL for males and , 50mg/dL for females. For ages 13–15y ears, HDL , 40mg/dL;
. High TG:T G $ 150mg/dL;
. Hypertension: SBP $ 130mmHg or DBP $ 85mmHg; and
. High Fasting Glucose: $ 100mg/dL.
b Insulin resistance, HOMA-IR . 3.16;
c Hyperinsulinemia, Insulin $ 30m U/ml for Tanner stage 4a nd $ 20m U/ml for Tanner stage 5.
Table III. Number of metabolic syndrome abnormalities, according to IDF 2009 criteria.
Adolescents, n (%)
Metabolic syndrome
abnormalities
Obese . þ 2B MI
z -scores ( n ¼ 104)
Overweight þ 1 , BMI
z -scores # þ 2( n ¼ 78)
Normal weight # þ 1B MI z -scores
( n ¼ 81)
One 44  (42.3) 33  (42.3) 32  (39.5)
Two3 5  (33.7) 20  (25.6) 4  (4.9)
Three 20  (19.2) 3  (3.8) 1  (1.2)
Four 2  (1.9) 0  (0.0) 0  (0.0)
Metabolic
syndrome
22  (21.2) 3  (3.8) 1  (1.2)
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et al. 2008). For instance, as tudy conducted in Norway
documented ac onsiderably higher prevalenceo fM Sa mong
overweight and obese children with Middle Eastern origins
as compared to their Norwegian counterparts (30.6% and
20.8%,r espectively) (Kolsgaard et al. 2008). It is in this
context that the use of criteria speciﬁc to race or ethnic
group for MS in youths is becoming highly warranted
(Sumner 2008).
The results of the present study clearly show that the
presenceo fi ndividual cardiometabolic risk factors was high
in obeses ubjects,w ith9 7.1%o fo bese adolescents
presenting with at least one MS abnormality( data not
shown). These ﬁndingsm ay place obese adolescents at
ah igher riskf or early manifestations of atherosclerosis,
as suggested by Whincup et al. (2005), whos howedt hat
brachial arteryd ispensabilityd ecreased in obese adolescents
as adiposity, IR, diastolic blood pressurea nd the other
criteriao fM Si ncreased.
Theﬁndingsofthisstudysuggestgenderdisparitiesinthe
prevalenceo fM S, with boys presenting higher prevalence
rates as compared to girls. This higher prevalence of MS in
boys is in agreement with previous studies conducted in
theUS(Cooketal.2003;W eissetal.2004),butcontradictory
tothosereportedfromIran,anotherMiddle-Easterncountry
(Esmaillzadeh et al. 2006). One reasonb ehind this gender
disparityi no ur studym ay be the higher prevalenceo fs evere
obesity( BMI . þ 3 Z -scores for sex and age) among boys
(8.0%)a sc ompared to girls (5.3%).
In addition to abdominal obesity, which was present in
the majorityo fs ubjects having the MS, thiss tudy showed
that lowH DL and elevatedT Gc ontributed most to MS
prevalence( 96.2% and7 3.1%,r espectively). Further analysis
of the data by logistic regression showedt hat the TG/HDL
ratio was as trongd eterminant of MS in the study sample
(OR ¼ 4.3, 95% CI ¼ 2.76–6.72). The highp revalence of
highT Gc oupled with low HDL (i.e. ah ighT G/HDL ratio)
among obese subjects has been noted previously as as trong
predictor of MS in Venezuelan children (6–12y ears)
(Quijadaetal.2008),promptinginvestigatorstoproposethe
use of the TG/HDL ratio as ap redictive indicator of MS in
children and adolescents (Hannon et al. 2006;D huper et al.
2007; Li et al. 2008). It is worth noting that, in an ational
study on the prevalenceo fM Sa mong Lebanese adults, low
HDL appeared as the most prevalent metabolic abnormality
in the studied population (49.3%) (Sibai et al. 2008). This
is supported by previous ﬁndingsw here reduced HDL
levels were reporteda st he most common metabolic
abnormalityamongadultArabAmericans(Jaberetal.2004).
In this study, 73.1%o fo bese adolescentsw ere
hyperinsulinemic and8 8.5% insulin-resistant, based on
Table V. Pearson correlation coefﬁcients of metabolic variables under study in subjects of both genders.
Variable %B FB MI WC HDL TG Glucose SBP DBP Insulin HOMA
%B F1 .000 0.726 0.453 0.049 0.299** 2 0.163** 0.011 0.130* 0.465** 0.232**
p -value –0 .000 0.000 0.430 0.000 0.008 0.863 0.035 0.000 0.000
BMI –1 .000 0.646** 2 0.188* 0.289** 2 0.111 0.292** 0.225** 0.326** 0.054
p -value –0 .000 0.011 0.000 0.137 0.000 0.002 0.000 0.470
WC (cm) –– 1.000 2 0.155* 0.344** 0.008 0.343** 0.345** 0.176* 2 0.007
p -value –– 0.037 0.000 0.912 0.000 0.000 0.017 0.922
HDL (mg/dL) –– –1 .000 2 0.336** 2 0.029 2 0.104 2 0.102 2 0.204** 2 0.161*
p -value –– –0 .000 0.693 0.164 0.169 0.006 0.030
TG (mg/dL) –– –– 1.000 2 0.006 0.053 0.168* 0.212** 0.161*
p -value –– –– 0.931 0.480 0.023 0.004 0.030
Glucose (mg/dL) –– –– –1 .000 0.024 0.122 0.162* 0.184*
p -value –– –– –0 .745 0.101 0.029 0.013
SBP (mmHg) –– –– –– 1.000 0.474** 0.020 2 0.045
p -value –– –– –– 0.000 0.790 0.548
DBP (mmHg) –– –– ––– 1.000 0.030 0.038
p -value –– –– ––– 0.690 0.612
Insulin ( m U/mL) –– –– –––– 1.000 0.411**
p -value –– –– –––– 0.000
BF,B ody fat; DBP,D iastolic Blood pressure; HDL-C, High Density lipoprotein-Cholesterol; IR, Insulin Resistance; SBP,S ystolic blood pressure; TG,
Triglycerides; WC,W aist circumference.
* p , 0.05; ** p , 0.01.
Table IV.I ndividual abnormalities among subjects with metabolic
syndrome ( n ¼ 26), according to IDF (2009).
Individual
abnormalities
Subjects with the metabolic
syndrome, n (%)
Elevated WC
a 25  (96.2)
Low HDL
a 25  (96.2)
High TG
a 19  (73.1)
Hypertension
a 9  (34.6)
High fasting glucose
a 2  (7.7)
Insulin resistance
b 26  (100.0)
Hyperinsulinemia
c 19  (73.1)
a As deﬁned by IDF Criteria:
. Elevated Waist Circumference (WC): For subjects 16 years and older,
WC $ 94cm for males and $ 80cm for females. For ages 13–15y ears,
WC $ 90th percentiles or adult cut-off value if lower.
. Low HDL: For subjects 16 years and older HDL , 40mg/dL for males
and , 50mg/dL for females. For ages 13–15y ears, HDL , 40mg/dL;
. High TG:T G $ 150mg/dL;
. Hypertension: SBP $ 130mmHg or DBP $ 85mmHg; and
. High Fasting Glucose: $ 100mg/dL.
b Insulin resistance, HOMA-IR . 3.16;
c Hyperinsulinemia, Insulin $ 30
m U/ml for Tanner stage 4a nd $ 20m U/ml for Tanner stage 5.
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from France( Druet et al. 2006) where 71.8%o fo bese
children and adolescents were insulin-resistant, but higher
than estimatesr eported from Bolivia (39.4%)( Caceres et al.
2008), Italy (40.8%)( Valerioe ta l. 2006), Spain (45.4%)
(Tapia Ceballos et al. 2007)a nd Mexico (51%)( Juarez-
Lopez et al. 2010). Hyperinsulinemia serves to compensate
for IR to maintaing lucose homeostasis (Eyzaguirrea nd
Mericq 2009), as evidenced by the fact that the least
common abnormalityi nt he study subjects wase levated
fasting bloodg lucose. Adolescents with hyperinsulinemia
and IR are prone to several health problems, including
systemic inﬂammation, endothelial dysfunction, hyperten-
sion, polycysticovarys yndrome and early atherosclerosis, all
of which can appear during childhood anda dolescencei n
obese individuals( Eyzaguirrea nd Mericq 2009;S teinberger
et al. 2009; Juarez-Lopez et al. 2010). IR has also been
suggested to play ap ivotal role in the pathogenesis of MS as
evidenced by the fact that, in this study, IR was found in all
subjects having MS.T hisc entral role of IR in the
development of MS is corroboratedb yr esults from other
studies in American, Mexican and Bolivianyouth suggesting
that MS is more likely to develop in childrena nd adolescents
with hyperinsulinemia (Cruz and Goran 2004;C aceres et al.
2008; Shaibi and Goran 2008;J uarez-Lopez et al. 2010). IR
has thus been suggested as being as igniﬁcantp redictor of
the paediatricM Sa nd was proposed as ad iagnostict ooli n
childrenandadolescents(Tresacoetal.2005;Leeetal.2007).
In this study, regressiona nalyses showed that %BF,
BMIand WC were relatively similar in their ability to predict
MS and that body fat was not superior to either BMI
or WC in predicting metabolic risk in obesea dolescents.
Theseﬁ ndingsa re in agreement with those reported by
Neovius et al. (2009) in Swedish adolescents and Lindsay
et al. (2001)i nP ima Indian adolescents, thus underscoring
the utilityo fB MI as an adiposityi ndicator and ap redictor
of cardiovascularr isk factors in this age group.B MI
was suggested by Sen et al. (2008)a st he most important
determinant of MS in as tudy on obesec hildrena nd
adolescents in Turkey,w herebyaone-point increase in BMI
Z -score resulted in a2 -foldi ncrease in the prevalenceo f
MS (Sen et al. 2008).
CONCLUSIONS
In conclusion, this study is, to our knowledge, the ﬁrst in the
Levant area and in Lebanon to investigate the magnitude of
the associationb etween obesitya nd components of the MS
in an adolescent population group.T he ﬁndingss howed
that the prevalenceo fm etabolic abnormalities and their
clustering into MS increasedw ith obesitya nd that BMI, WC
and %BF were signiﬁcant predictors of MS in thisa ge
group.T heseﬁ ndings highlightt he importance of early
screening for metabolic abnormalities in adolescent obesity
and stress the importance of early weight management
intervention strategies as the burden of comorbidities may
be reversed if health risks are identiﬁed and treated early in
life (Battista et al. 2009).
The results of this study should be considered in light
of the following limitations. Elevated WC was determined,
as recommended, according to cut-off points speciﬁc for
Europids duet ot he unavailability of WC cut-off
values speciﬁc for ourp opulation. Hyperinsulinemia was
also identiﬁed based on international cut-off points due
to the lack of an upper limito fi nsulinv aluesf or Lebanese
population. Finally,w eh aveu sed fasting glucose and insulin
values in the HOMA equation to estimate IR, rather than
other more accurate techniquess uch as the euglycemic
clamp.
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